Advancements in skin cancer treatment: 5-fluorouracil and carvedilol-loaded transethosomes using Lipoid S100
The combination of 5-FU and CVD within a transethosome-based delivery system presents a potential alternative for topical chemotherapy in skin cancer treatment, offering enhanced therapeutic efficacy. This study underscores the potential of hybrid drug carriers in advancing targeted cancer therapies.
Authors
- Prafull Shinde (ORCID: https://orcid.org/0000-0002-4654-0083)
- Amit Page (ORCID: https://orcid.org/0000-0001-9735-1197)
Institutions
- Narsee Monjee Institute of Management Studies (IN)
- Shri Vile Parle Kelavani Mandal (IN)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1080/03639045.2025.2485313
- Citations
- 3
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 2.37